Agility in Manufacturing Preparedness Act of 2025

Bill 119 s 1305, also known as the "Biomedical Advanced Research and Development Authority and Manufacturing USA Collaboration Act," aims to enhance collaboration between the Biomedical Advanced Research and Development Authority (BARDA) and the network of Manufacturing USA institutes.

The bill seeks to promote the development and manufacturing of medical countermeasures, such as vaccines, drugs, and diagnostics, by fostering partnerships between BARDA and the Manufacturing USA institutes. These institutes are public-private partnerships that focus on advanced manufacturing technologies and processes.

By encouraging collaboration between BARDA and the Manufacturing USA institutes, the bill aims to leverage the expertise and resources of both entities to accelerate the development and production of medical countermeasures. This collaboration is crucial for ensuring that the United States is prepared to respond to public health emergencies, such as pandemics or bioterrorism threats. Overall, Bill 119 s 1305 aims to strengthen the nation's ability to respond to public health emergencies by facilitating greater collaboration between BARDA and the Manufacturing USA institutes. This collaboration will help to ensure that the United States has the necessary medical countermeasures to protect the health and safety of its citizens in times of crisis.